ADPT

Adeptus Health Inc.
ADPT

Delisted

ADPT was delisted on the 19th of April, 2017.

Back to rankings
Healthcare Medical Care Facilities

Financial journalist opinion

Positive
Zacks Investment Research
4 hours ago
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
Neutral
GlobeNewsWire
yesterday
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY.
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Positive
Zacks Investment Research
4 days ago
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
Positive
Zacks Investment Research
16 days ago
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
Positive
Zacks Investment Research
21 days ago
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
Positive
Seeking Alpha
21 days ago
Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts
Adaptive Biotechnologies and Netflix were top contributors, driven by strong earnings, momentum in core businesses, and positive outlooks. UnitedHealth Group and Visa detracted from performance due to earnings weakness, guidance cuts, and potential disruption from stablecoins. We initiated a position in HubSpot for its strong SMB positioning, AI-driven growth, and scalable financials, while exiting Expedia due to recession risks.
Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts
Positive
The Motley Fool
22 days ago
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
Just after market close, Adaptive Biotechnologies (ADPT 5.97%) took the wraps off its second quarter. The following day, investors reacted to this by bidding the biotech company's stock up by almost 6%.
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
Positive
The Motley Fool
23 days ago
Adaptive (ADPT) Q2 Revenue Surges 36%
Adaptive (ADPT) Q2 Revenue Surges 36%
Adaptive (ADPT) Q2 Revenue Surges 36%
Neutral
Seeking Alpha
23 days ago
Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Chad M. Robins - Co-Founder, CEO & Chairman Karina Calzadilla - Vice President of Investor Relations Kyle Piskel - VP, CFO & Principal Accounting Officer Susan Bobulsky - Chief Commercial Officer of MRD Conference Call Participants Andrew Frederick Brackmann - William Blair & Company L.L.C.
Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
23 days ago
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings
While the top- and bottom-line numbers for Adaptive Biotechnologies (ADPT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings
See News Rankings
Charts implemented using Lightweight Charts™